Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. immunodeficient
Show results for
Products
Services
Training

Companies

News
Articles
Books
Downloads
Videos

Refine by
Date

  • Older

Immunodeficient Articles & Analysis: Older

14 news found

CD BioGlyco Updated Its Glycoprotein Quantification Service Recently

CD BioGlyco Updated Its Glycoprotein Quantification Service Recently

Changes in glycoprotein abundance and glycan structures are closely linked to various diseases, including genetic disorders, immunodeficiencies, cardiovascular diseases, and cancer. The updated service from CD BioGlyco contains: Relative Quantification of Glycoprotein CD BioGlyco provides relative quantification of glycoprotein at the site-specific glycosylation level/protein ...

ByCD BioGlyco.


Advanced Lung Function Measurement In A Novel HIV/Tuberculosis Co-Infection Mouse Model

Advanced Lung Function Measurement In A Novel HIV/Tuberculosis Co-Infection Mouse Model

Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) are major global health threats. Their interaction worsens disease severity, as HIV reduces CD4+ T cells, making individuals more vulnerable to TB. ...

BySCIREQ - an emka TECHNOLOGIES Company


CD Genomics Longseq Division Unveils Human Leukocyte Antigen (HLA) Typing Service

CD Genomics Longseq Division Unveils Human Leukocyte Antigen (HLA) Typing Service

There are more than 100 kinds of diseases related to HLA, involving autoimmune diseases, immunodeficiency diseases, allergic diseases, infectious diseases, metabolic diseases, and so on. ...

ByCD Genomics


Preclinical Data on Novel Arenaviral HIV Therapeutic Vaccines Presented at Keystone Symposium

Preclinical Data on Novel Arenaviral HIV Therapeutic Vaccines Presented at Keystone Symposium

(NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, announced preclinical data, in collaboration with Gilead Sciences, Inc., on arenaviral therapeutic vaccines that are being studied as a component of a potential functional curative regimen for human immunodeficiency virus (HIV). These data ...

ByHookipa Pharma Inc.


Rocket Pharmaceuticals Presents Positive Top-line Data from Severe Leukocyte Adhesion Deficiency-I Program at the 25th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)

Rocket Pharmaceuticals Presents Positive Top-line Data from Severe Leukocyte Adhesion Deficiency-I Program at the 25th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)

“We are excited to present positive top-line safety and efficacy data from our Phase 2 pivotal trial for LAD-I today at ASGCT, representing a significant step forward in the development of RP-L201 for the treatment of LAD-I, one of the most aggressive and highly fatal immunodeficiencies ever characterized. Moreover, they point to the great possibilities lentiviral-based ...

ByRocket Pharmaceuticals, Inc.


Atriva Therapeutics announces efficacy of its lead compound zapnometinib against Omicron

Atriva Therapeutics announces efficacy of its lead compound zapnometinib against Omicron

While Omicron is relatively less pathogenic than previous variants like Delta, it remains a lethal threat to those patients who cannot be vaccinated or have a combination of risk factors including advanced age or immunodeficiency. Due to the high number of escape mutations in Omicron, previous vaccinations may be less protective against this variant of SARS-CoV-2. ...

ByAtriva Therapeutics GmbH


Hemostemix to combine ACP-01 with Dr. James Shapiro’s Islet Cells to treat Type 1 Diabetes

Hemostemix to combine ACP-01 with Dr. James Shapiro’s Islet Cells to treat Type 1 Diabetes

His group is actively researching personalized medicine approaches to pancreatic and other hepatobiliary cancers, with generation of human tumor transplantation in immunodeficient mouse models, using a novel pre-vascularized subcutaneous implantation site model. ...

ByHemostemix Inc.


Profacgen Helps Accelerate GPCR Study with Various Services

Profacgen Helps Accelerate GPCR Study with Various Services

GPCR screening and analysis technology is now widely used in new drug screening for infectious diseases, cardiovascular disease, mental illness, acquired immunodeficiency syndrome (AIDS), diabetes, cancer and so on. Based on years’ experience, Profacgen now provides a comprehensive list of services to help with its customers’ GPCR study. ...

ByProfacgen


AIVITA Biomedical’s Stem Cell-Derived Retina Transplant Restores Vision Loss in Preclinical Study

AIVITA Biomedical’s Stem Cell-Derived Retina Transplant Restores Vision Loss in Preclinical Study

– Oct. 29, 2021 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, today announced the publication of the peer-reviewed manuscript, “Co-grafts of Human Stem Cell-Derived Retina Organoids and Retinal Pigment Epithelium for Retinal Reconstruction in Immunodeficient Retinal Degenerate Royal College of Surgeons ...

ByAIVITA Biomedical, Inc.


BOC Sciences Becomes the Largest PseudoUridine Supplier in the World

BOC Sciences Becomes the Largest PseudoUridine Supplier in the World

It is considered to be a regulator of the latent process of the human immunodeficiency virus (HIV) infection. In addition to pseudoUridine, pseudoUridine derivatives such as 1-methylpseudoUridine, 3-methylpseudoUridine, 2'-O-methylpseudoUridine and ultramodified residue 1 -Methyl-3-(3-amino-3-carboxypropyl) pseudoUridine are also popular products of BOC Sciences. ...

ByBOC Sciences


First Preclinical Data from Adaptimmune’s Mesothelin HiT Program at ASGCT Demonstrate Antigen-specific Tumor Cell Killing in vitro and Complete Tumor Regression in an Animal Model

First Preclinical Data from Adaptimmune’s Mesothelin HiT Program at ASGCT Demonstrate Antigen-specific Tumor Cell Killing in vitro and Complete Tumor Regression in an Animal Model

Adaptimmune’s HiTs are CD8 and HLA-independent and kill mesothelin expressing human tumor cells Human T-cells expressing the mesothelin-targeted HiT kill human tumor cell lines and primary human lung tumor cells expressing mesothelin Data demonstrate that the mesothelin HiT is not dependent on CD8 to kill target cells, and CD4 cells expressing the HiT are cytotoxic towards tumor cells ...

ByAdaptimmune LLC


Techcomp Products for Medical Marijuana

Techcomp Products for Medical Marijuana

Medical marijuana uses the chemicals within the marijuana plant to help reduce pain and treat certain diseases. The plant contains more than 100 different chemicals called cannabinoids. Each one has a different effect on the body, with delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) being the main chemicals used in ...

ByEdinburgh Sensors Ltd - TECHCOMP Group


Grifols reaches revenue of EUR 5,100 million, a 13.6% increase, and raises its profits to EUR 625 million

Grifols reaches revenue of EUR 5,100 million, a 13.6% increase, and raises its profits to EUR 625 million

These markets, in addition to using immunoglobulins to treat primary immunodeficiencies, also utilize them to treat secondary immunodeficiencies and neurological diseases like chronic inflammatory demyelinating polyneuropathy (CIPD). ...

ByGrifols International, S.A.


CSL Behring Awards advocacy grants to patient groups in Maryland, New England, the Midwest and Washington

CSL Behring Awards advocacy grants to patient groups in Maryland, New England, the Midwest and Washington

"The IDF thanks CSL Behring for the LEAD grant and for letting the voices of those with primary immunodeficiencies be heard," Lawrence A. LaMotte, Director Public Policy, IDF, said. ...

ByCSRwire - Corporate Social Responsibility Newswire

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT